Swiss National Bank
VIVO

Swiss National Bank’s Meridian Bioscience Inc VIVO Stock Holding History

Swiss National Bank’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-105,600
Closed -$3.51M – 2706
2022
Q4 		$3.51M Buy
105,600
+2,300
+2% +$74.1K ﹤0.01% 1532
2022
Q3 		$3.26M Buy
103,300
+700
+0.7% +$22.7K ﹤0.01% 1546
2022
Q2 		$3.12M Buy
102,600
+5,200
+5% +$141K ﹤0.01% 1616
2022
Q1 		$2.53M Buy
97,400
+7,100
+8% +$169K ﹤0.01% 1899
2021
Q4 		$1.84M Hold
90,300
– – ﹤0.01% 2117
2021
Q3 		$1.74M Hold
90,300
– – ﹤0.01% 2142
2021
Q2 		$2M Sell
90,300
-8,200
-8% -$174K ﹤0.01% 2093
2021
Q1 		$2.59M Buy
98,500
+1,400
+1% +$33.3K ﹤0.01% 1866
2020
Q4 		$1.81M Hold
97,100
– – ﹤0.01% 1960
2020
Q3 		$1.65M Buy
97,100
+1,500
+2% +$29.2K ﹤0.01% 1812
2020
Q2 		$2.23M Buy
95,600
+13,800
+17% +$200K ﹤0.01% 1654
2020
Q1 		$687K Hold
81,800
– – ﹤0.01% 2029
2019
Q4 		$799K Buy
81,800
+2,800
+4% +$26.3K ﹤0.01% 2256
2019
Q3 		$750K Hold
79,000
– – ﹤0.01% 2203
2019
Q2 		$939K Buy
79,000
+1,700
+2% +$20.5K ﹤0.01% 2150
2019
Q1 		$1.36M Buy
77,300
+2,300
+3% +$38.3K ﹤0.01% 1891
2018
Q4 		$1.3M Buy
75,000
+1,500
+2% +$25.6K ﹤0.01% 1832
2018
Q3 		$1.09M Hold
73,500
– – ﹤0.01% 2100
2018
Q2 		$1.17M Hold
73,500
– – ﹤0.01% 2066
2018
Q1 		$1.04M Buy
73,500
+3,900
+6% +$57.7K ﹤0.01% 2052
2017
Q4 		$974K Hold
69,600
– – ﹤0.01% 2108
2017
Q3 		$995K Hold
69,600
– – ﹤0.01% 2065
2017
Q2 		$1.1M Hold
69,600
– – ﹤0.01% 1996
2017
Q1 		$960K Buy
69,600
+3,100
+5% +$43.3K ﹤0.01% 2064
2016
Q4 		$1.18M Hold
66,500
– – ﹤0.01% 1925
2016
Q3 		$1.28M Sell
66,500
-2,500
-4% -$48.9K ﹤0.01% 1814
2016
Q2 		$1.35M Buy
69,000
+1,700
+3% +$33.3K ﹤0.01% 1781
2016
Q1 		$1.34M Buy
67,300
+12,700
+23% +$250K ﹤0.01% 1721
2015
Q4 		$1.12M Hold
54,600
– – ﹤0.01% 1735
2015
Q3 		$934K Buy
54,600
+6,000
+12% +$110K ﹤0.01% 1817
2015
Q2 		$906K Buy
48,600
+2,000
+4% +$37.1K ﹤0.01% 1844
2015
Q1 		$889K Buy
46,600
+1,400
+3% +$25.9K ﹤0.01% 1822
2014
Q4 		$744K Hold
45,200
– – ﹤0.01% 1908
2014
Q3 		$800K Sell
45,200
-900
-2% -$17.7K ﹤0.01% 1801
2014
Q2 		$952K Hold
46,100
– – ﹤0.01% 1749
2014
Q1 		$1M Buy
46,100
+10,500
+29% +$241K ﹤0.01% 1707
2013
Q4 		$944K Hold
35,600
– – ﹤0.01% 1553
2013
Q3 		$842K Sell
35,600
-1,900
-5% -$44.4K ﹤0.01% 1573
2013
Q2 		$806K Buy
+37,500
New +$809K ﹤0.01% 1573

Other funds holding VIVO

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Swiss National Bank's VIVO Position: Q1 2023 in Review

Swiss National Bank sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 105,600 shares — an estimated $3.51M sold.

Swiss National Bank first reported a position in VIVO in Q2 2013 and held it in 39 quarters. The position peaked at $3.51M in Q4 2022. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

  • Swiss National Bank reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
  • Swiss National Bank sold 105,600 Meridian Bioscience Inc shares in Q1 2023, an estimated $3.51M.
  • Swiss National Bank first reported a position in Meridian Bioscience Inc in Q2 2013 and held it in 39 quarters.
  • Swiss National Bank's Meridian Bioscience Inc position peaked at $3.51M in Q4 2022.
  • 2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on Swiss National Bank's 13F filing for Q1 2023, filed 10 May 2023.